1h0d: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1h0d.gif|left|200px]]
{{Seed}}
[[Image:1h0d.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1h0d|  PDB=1h0d  |  SCENE=  }}  
{{STRUCTURE_1h0d|  PDB=1h0d  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F'''
===CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F===




==Overview==
<!--
The murine monoclonal antibody 26-2F neutralizes the angiogenic and ribonucleolytic activities of human angiogenin (ANG) and is highly effective in preventing the establishment and metastatic dissemination of human tumors in athymic mice. Here we report a 2.0 A resolution crystal structure for the complex of ANG with the Fab fragment of 26-2F that reveals the detailed interactions between ANG and the complementarity-determining regions (CDRs) of the antibody. Surprisingly, Fab binding induces a dramatic conformational change in the cell binding region of ANG at the opposite end of the molecule from the combining site; crosslinking experiments indicate that this rearrangement also occurs in solution. The ANG-Fab complex structure should be invaluable for designing maximally humanized versions of 26-2F for potential clinical use.
The line below this paragraph, {{ABSTRACT_PUBMED_12842050}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 12842050 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_12842050}}


==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Antibody]]
[[Category: Antibody]]
[[Category: Ribonuclease]]
[[Category: Ribonuclease]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 18:15:21 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 06:24:47 2008''